A 48-year-old man with a 3-year history of Meniere disease (confirmed by electrocochleography) now presents with progressive bilateral hearing loss and recurrent vertigo. His audiogram shows low-frequency sensorineural hearing loss bilaterally. Which investigation is most appropriate to assess for secondary endolymphatic hydrops and rule out retrocochlear pathology?

## Investigation for Bilateral Meniere and Retrocochlear Exclusion ### MRI with Gadolinium and Delayed T2-Weighted Imaging **Key Point:** MRI with intravenous gadolinium and delayed T2-weighted imaging is the gold standard for visualizing endolymphatic hydrops and excluding retrocochlear lesions (acoustic neuroma, meningioma) in patients with atypical or bilateral presentation. **High-Yield:** The gadolinium-enhanced T2-weighted sequence (obtained 4 hours after IV gadolinium administration) shows: - **Dilated endolymphatic space** (bright signal on T2, suppressed on gadolinium-enhanced images) - **Cochlear hydrops** (enlargement of cochlear duct) - **Vestibular hydrops** (enlargement of saccule/utricle) - **Retrocochlear masses** (acoustic neuroma, meningioma) as gadolinium-enhancing lesions **Clinical Pearl:** Bilateral Meniere disease occurs in 15–30% of cases. The presence of bilateral symptoms or progressive unilateral disease with atypical features mandates imaging to exclude secondary causes (retrocochlear tumors, autoimmune inner ear disease, superior semicircular canal dehiscence). ### Why MRI Is Superior in This Context | Investigation | Detects Hydrops | Detects Retrocochlear Mass | Radiation | Best Use | |---|---|---|---|---| | **MRI + Gad + Delayed T2** | Yes (direct visualization) | Yes (excellent) | None | Bilateral/atypical Meniere; rule-out retrocochlear | | High-res CT temporal bone | No (indirect signs only) | Poor (no soft tissue contrast) | Yes | Osseous anatomy; SSCD; dehiscence | | VNG | No | No | None | Vestibular function; nystagmus pattern | | Posturography | No | No | None | Balance/fall risk; rehabilitation | ### Diagnostic Algorithm for Bilateral Meniere ```mermaid flowchart TD A[Bilateral vertigo + hearing loss]:::outcome --> B{Unilateral or bilateral?}:::decision B -->|Unilateral, typical| C[Audiometry + ECochG]:::action B -->|Bilateral or atypical| D[MRI with Gad + Delayed T2]:::action D --> E{Hydrops visible?}:::decision E -->|Yes, no mass| F[Bilateral Meniere]:::outcome E -->|Yes + enhancing lesion| G[Retrocochlear pathology]:::urgent E -->|No hydrops| H[Consider alternative diagnosis]:::outcome H --> I[AIED, SSCD, vestibular migraine]:::outcome ``` **Key Point:** MRI is non-invasive, radiation-free, and provides both morphologic (hydrops) and contrast-enhanced (tumor) information in a single study. **Mnemonic:** **MRI-GAD-T2** = **M**RI with **R**adial **I**nversion, **GAD**olinium, and **T2**-weighted imaging for **H**ydrops and **T**umor detection. ### When to Order MRI in Meniere Disease 1. **Bilateral symptoms** (15–30% of cases) 2. **Atypical presentation** (progressive hearing loss, no vertigo; vertigo without hearing loss) 3. **Rapidly progressive unilateral disease** 4. **Asymmetric hearing loss** on audiometry 5. **Failure to respond** to standard medical therapy 6. **Retrocochlear signs** on audiometry (poor speech discrimination, acoustic reflex abnormality) [cite:Harrison 21e Ch 468; Gürkov et al. MRI in Meniere's Disease: A Consensus Report. JAMA Otolaryngol Head Neck Surg 2018]